Ursula Matulonis, MD

Ursula Matulonis, MD

Medical Director, Medical Gynecologic Oncology
Disease Center Leader, Medical Gynecologic Oncology Program
Dana-Farber Cancer Institute
Associate Professor, Medicine
Harvard Medical School

Ursula A. Matulonis, MD, is Chief and Director of the Division of Gynecologic Oncology at the Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School.  She is the first recipient of the Brock-Wilson Family Chair at the Dana-Farber Cancer Institute.  She also co-leads the Ovarian Cancer Program within the Dana-Farber/Harvard Cancer Center.  Her research focuses on developing new targeted therapies for gynecologic malignancies, with a specific interest in ovarian cancer and endometrial cancer.

Dr. Matulonis has led several PARP inhibitor, anti-angiogenic agent, immunotherapy, and combination trials for ovarian cancer in the United States and internationally.  Dr. Matulonis serves on the Massachusetts Ovarian Cancer Task Force, the NRG ovarian committee, and the Scientific Advisory Board for the Ovarian Cancer Research Alliance and the Clearity Foundation.  She received the Dana-Farber Dennis Thompson Compassionate Care Scholar award, the Lee M. Nadler “Extra Mile” Award, the Clearity Foundation award, and the Zakim Award at Dana-Farber for patient advocacy.

After receiving her MD from Albany Medical College, she completed an internship and residency at the University of Pittsburgh, followed by a medical oncology fellowship at the Dana-Farber Cancer Institute in Boston, MA.